To improve the modernization level of pharmaceutical industry, we need to make a breakthrough in pharmaceutical equipment

To improve the modernization level of pharmaceutical industry, we need to make a breakthrough in pharmaceutical equipment

Data show that in 2020, China's fixed asset investment will reach 51890.7 billion yuan, an increase of 2.9% over the previous year. The pharmaceutical industry has brought strong support to the manufacturing industry, and the investment growth rate of the pharmaceutical manufacturing industry will reach 28.4% in 2020. It is reported that during the 14th Five Year Plan period, China's pharmaceutical industry will achieve seven major goals. One of them is to improve the modernization level of the industrial chain supply chain, make up for the short plate and forging long plate, and solve a number of neck problems as soon as possible. The key tasks also mentioned that we should promote key enterprises to achieve breakthroughs in drug design, production technology, high-end excipients, pharmaceutical equipment and other aspects.

As the "mother machine" of pharmaceutical production, pharmaceutical equipment plays an important role in pharmaceutical manufacturing. At present, under the background of investment growth of pharmaceutical manufacturing industry and favorable policies supporting industrial modernization development, pharmaceutical equipment industry is facing both opportunities and challenges.

Equipment demand growth

The industry is ushering in a new round of boom

According to the data, in 2020, the pharmaceutical special equipment manufacturing industry will achieve a total revenue of 19.787 billion yuan, with a year-on-year growth of 14.57% and a profit margin of 6.44%. This set of data means that in 2015, due to the decrease of equipment demand after the GMP certification peak, the situation of the industry's income and profit decline has changed, and the industry's recovery trend is obvious.

In addition, with the growth of investment in pharmaceutical manufacturing industry in 2020, the demand of pharmaceutical enterprises for the process and equipment required for R & D and industrialization in the industrial chain will continue to expand. In this context, the demand for pharmaceutical equipment is expected to grow, and the industry believes that the industry is ushering in a new round of boom.

In fact, from the data of listed pharmaceutical machinery enterprises that have disclosed the annual data of 2020 and the first quarterly report of 2021, we can also explore the prosperity of the industry. Despite the impact of the epidemic in the first quarter of 2020, after entering the second quarter, the performance of most enterprises improved and still achieved a certain growth in the whole year. In addition, the net profit growth of pharmaceutical machinery enterprises such as Dong Fulong doubled. In 2021, many pharmaceutical machinery enterprises have shown that they have sufficient orders and their performance is in the release period.

Promote the modernization of pharmaceutical industry

There are still several bottlenecks to be solved in the pharmaceutical machinery industry

At present, there are many kinds of products in China's pharmaceutical equipment market with complete specifications and large output, which can basically meet the needs of domestic pharmaceutical enterprises. However, there are still several bottlenecks to be overcome in promoting the modernization of the pharmaceutical industry.

First, technical bottleneck. After years of development, the domestic pharmaceutical equipment industry has made some progress in process technology. However, some pharmaceutical machinery products such as centrifuges mainly rely on imported parts and technology, which is limited by people. Therefore, to promote the modernization of pharmaceutical industry, we need to break the bottleneck of traditional technology, innovate technology and process products, and realize the high-end development of pharmaceutical machinery industry.

Second, the level of innovation. Due to the small scale and weak capital of most enterprises, there are obvious shortcomings in innovation, which leads to the low-level repeated production of domestic pharmaceutical machinery, and the phenomenon of product homogenization is serious, even among large pharmaceutical machinery enterprises. Under the background of the continuous improvement of pharmaceutical product quality requirements and industry standards, it is necessary to improve the innovation level of pharmaceutical equipment. For pharmaceutical machinery enterprises, with the increasingly fierce market competition in pharmaceutical machinery industry, strengthening investment in product innovation and R & D and actively seeking the road of innovation and transformation are also means to enhance the competitiveness of enterprises.

Epilogue

2021 is the first year of China's 14th five year plan. It is the general trend of various industries, including pharmaceutical equipment industry, to promote industrial upgrading by scientific and technological innovation and to promote sustained and high-quality economic development. Facing the new year, pharmaceutical equipment industry enterprises still need to make up for the shortcomings, overcome the "hard bone", realize the innovation and upgrading of domestic pharmaceutical equipment, help to improve the modernization level of pharmaceutical manufacturing industry, and promote the high-quality development of the industry.